Camelia Iancu‐Rubin
Mount Sinai Health System(US)New York Blood Center(US)Mount Sinai Hospital(US)Icahn School of Medicine at Mount Sinai(US)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Platelet Disorders and Treatments, Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research
Most-Cited Works
- → Platelets contribute to disease severity in COVID‐19(2021)196 cited
- → Stromal cell-mediated inhibition of erythropoiesis can be attenuated by Sotatercept (ACE-011), an activin receptor type II ligand trap(2012)100 cited
- → Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms(2019)100 cited
- → Activation of p53 by the MDM2 inhibitor RG7112 impairs thrombopoiesis(2013)86 cited
- → Neonatal expression of RNA-binding protein IGF2BP3 regulates the human fetal-adult megakaryocyte transition(2017)56 cited
- → Panobinostat (LBH589)-induced acetylation of tubulin impairs megakaryocyte maturation and platelet formation(2012)53 cited